TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 3901661

Group type: EXPERIMENTAL
Intervention: Cholestyramine 2 g twice daily
Number of subjects: 41

Group type: EXPERIMENTAL
Intervention: Loperamide 0.10 mg/kg divided in three doses
Number of subjects: 41

Group type: COMPARATOR
Intervention: Placebo 2 g twice daily
Number of subjects: 41
Study: 30142767

Group type: EXPERIMENTAL
Intervention: Socheongryong-tang (SCRT) taken twice daily for 2 weeks
Number of subjects: 30

Group type: COMPARATOR
Intervention: Cetirizine taken once daily for 2 weeks
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: SCRT
Number of subjects: 30

Group type: COMPARATOR
Intervention: SCRT and Cetirizine
Number of subjects: 30
Study: 27108685

Group type: COMPARATOR
Intervention: Central Europe (CE)
Number of subjects: 7141

Group type: COMPARATOR
Intervention: Western Europe (WE)
Number of subjects: 7141

Group type: COMPARATOR
Intervention: Asia-Pacific (AP)
Number of subjects: 7141

Group type: COMPARATOR
Intervention: Latin America (LA)
Number of subjects: 7141

Group type: COMPARATOR
Intervention: 180-day mortality
Number of subjects: 7141
Study: 25095325

Group type: COMPARATOR
Intervention: RHg
Number of subjects: 39

Group type: COMPARATOR
Intervention: RHg + RME
Number of subjects: 39

Group type: COMPARATOR
Intervention: Control (C)
Number of subjects: 39
Study: 22801290

Group type: EXPERIMENTAL
Intervention: Ziprasidone
Number of subjects: 23

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 23
Study: 20437771

Group type: EXPERIMENTAL
Intervention: Multidisciplinary groups (MultiG, n = 7)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Medical student groups (MedG, n = 10)
Number of subjects: 20
Study: 18515897

Group type: EXPERIMENTAL
Intervention: Schema-focused therapy (SFT)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Transference-focused psychotherapy (TFP)
Number of subjects: 0
Study: 15905006

Group type: EXPERIMENTAL
Intervention: Prediction model for back strength (moment at L4/L5)
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Prediction model for back strength (force)
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Validation study of prediction models
Number of subjects: 80
Study: 14558052

Group type: EXPERIMENTAL
Intervention: Intensive dynamic exercise program (75 minutes, twice a week, for 2 years)
Number of subjects: 146

Group type: EXPERIMENTAL
Intervention: Intensive dynamic exercise program
Number of subjects: 146
Study: 10811664

Group type: EXPERIMENTAL
Intervention: Interferon alpha consolidation (n = 144)
Number of subjects: 571

Group type: COMPARATOR
Intervention: Observation alone (n = 124)
Number of subjects: 571
Study: 8797643

Group type: EXPERIMENTAL
Intervention: Transanal endoscopic microsurgery (TEM; n = 24)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Anterior resection (AR; n = 26)
Number of subjects: 50
Study: 1594789

Group type: EXPERIMENTAL
Intervention: Halothane
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Isoflurane
Number of subjects: 60
Study: 6749152

Group type: EXPERIMENTAL
Intervention: vitamin K2 6 mg
Number of subjects: 148

Group type: EXPERIMENTAL
Intervention: vitamin K2 2 mg
Number of subjects: 148

Group type: EXPERIMENTAL
Intervention: vitamin K1 2 mg
Number of subjects: 148

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 148
Study: 30880626

Group type: EXPERIMENTAL
Intervention: Bimatoprost
Number of subjects: 31

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 31
Study: 29021322

Group type: EXPERIMENTAL
Intervention: Intensive systolic blood pressure control (target <120 mm Hg)
Number of subjects: 9361

Group type: COMPARATOR
Intervention: Standard systolic blood pressure control (target <140 mm Hg)
Number of subjects: 9361

Group type: EXPERIMENTAL
Intervention: Intensive systolic blood pressure control
Number of subjects: 9361

Group type: COMPARATOR
Intervention: Standard systolic blood pressure control
Number of subjects: 9361
Study: 26752599

Group type: EXPERIMENTAL
Intervention: Lipid-based nutrient supplements (LNS)
Number of subjects: 1546

Group type: EXPERIMENTAL
Intervention: Corn-soy blended flours (CSB)
Number of subjects: 1546

Group type: EXPERIMENTAL
Intervention: Both CSB and LNS
Number of subjects: 1546
Study: 24727030

Group type: EXPERIMENTAL
Intervention: Preoperative nebulization of 30mg ropivacaine
Number of subjects: 135

Group type: COMPARATOR
Intervention: Control group (saline solution instillation)
Number of subjects: 135
Study: 21815168

Group type: EXPERIMENTAL
Intervention: Dietary treatments with fish oil and vegetable oils
Number of subjects: 96
Study: 20185009

Group type: EXPERIMENTAL
Intervention: Ergocycle ramp protocol
Number of subjects: 16

Group type: COMPARATOR
Intervention: Bruce treadmill protocol
Number of subjects: 16

Group type: COMPARATOR
Intervention: Ramp treadmill protocol
Number of subjects: 16
Study: 16616883

Group type: EXPERIMENTAL
Intervention: Large box lifting (hand distance, 38 cm from chest)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Small box lifting (hand distance, 17 cm from chest)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Extended horizontal reach lifting (hand distance, 44.6 cm from chest)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: High frequency lifting (20 lifts/min)
Number of subjects: 10
Study: 16281375

Group type: EXPERIMENTAL
Intervention: Paroxetine
Number of subjects: 43

Group type: COMPARATOR
Intervention: Amitriptyline
Number of subjects: 43
Study: 12133866

Group type: EXPERIMENTAL
Intervention: Neutral endopeptidase (NEP) inhibition
Number of subjects: 7

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 7
Study: 10749457

Group type: EXPERIMENTAL
Intervention: Heptavalent CRM197 pneumococcal conjugate vaccine
Number of subjects: 37868

Group type: COMPARATOR
Intervention: Meningococcus type C CRM197 conjugate
Number of subjects: 37868
Study: 8958718

Group type: EXPERIMENTAL
Intervention: 5 micrograms/kg/min of amrinone (group A)
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: 10 micrograms/kg/min of amrinone (group B)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Control group (no amrinone)
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Amrinone (both groups)
Number of subjects: 18
Study: 1302788

Group type: EXPERIMENTAL
Intervention: Low dose midazolam
Number of subjects: 20

Group type: COMPARATOR
Intervention: Saline control
Number of subjects: 20
Study: 2938871

Group type: EXPERIMENTAL
Intervention: Infusion of alpha‐human atrial natriuretic peptide (alpha‐h‐ANP) at a dose of 15 pmol min‐1 kg‐1
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Infusion of alpha‐h‐ANP at a dose of 1.5 pmol min‐1 kg‐1
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Infusion of alpha‐h‐ANP
Number of subjects: 0
Study: 31881927

Group type: EXPERIMENTAL
Intervention: PIL B (hybrid format)
Number of subjects: 1517

Group type: COMPARATOR
Intervention: PIL A (enhanced format)
Number of subjects: 1517

Group type: COMPARATOR
Intervention: PIL C (standard format)
Number of subjects: 1517
Study: 29436052

Group type: EXPERIMENTAL
Intervention: Visually guided laser balloon ablation (VGLB)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Radiofrequency (RF) ablation
Number of subjects: 50
Study: 26838569

Group type: EXPERIMENTAL
Intervention: Text version of assessment items
Number of subjects: 48

Group type: COMPARATOR
Intervention: Multimedia version of assessment items
Number of subjects: 48
Study: 25353194

Group type: EXPERIMENTAL
Intervention: Powered wheelchair skills training (up to five 30‐min sessions based on the Wheelchair Skills Training Program 4.1)
Number of subjects: 17

Group type: COMPARATOR
Intervention: Control group (no training)
Number of subjects: 17
Study: 22237302

Group type: EXPERIMENTAL
Intervention: Carotenoid supplementation
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: GnRH challenge
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: GnRH challenge + carotenoid supplementation
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control
Number of subjects: 0
Study: 20026527

Group type: EXPERIMENTAL
Intervention: Not available
Number of subjects: 0
Study: 18031444

Group type: EXPERIMENTAL
Intervention: Early loading (6 weeks after implant placement)
Number of subjects: 29

Group type: COMPARATOR
Intervention: Delayed loading (6 months after implant placement)
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 29
Study: 16170942

Group type: EXPERIMENTAL
Intervention: Nonforced anchor group (n = 50)
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: Forced anchor group (n = 25)
Number of subjects: 75
Study: 11859853

Group type: EXPERIMENTAL
Intervention: Enalapril
Number of subjects: 82
Study: 10065670

Group type: COMPARATOR
Intervention: Regular nebulized salbutamol
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: As-required (p.r.n.) nebulized salbutamol
Number of subjects: 46
Study: 7733024

Group type: EXPERIMENTAL
Intervention: 15 mg zinc supplement (ZS, n = 40)
Number of subjects: 71

Group type: COMPARATOR
Intervention: Placebo (NZS, n = 31)
Number of subjects: 71

Group type: EXPERIMENTAL
Intervention: Both groups (ZS and NZS)
Number of subjects: 71

Group type: COMPARATOR
Intervention: Nonsupplemented group (NZS)
Number of subjects: 71
Study: 2144919

Group type: EXPERIMENTAL
Intervention: Mental stress by a letter informing them about their high blood pressure (Group 1)
Number of subjects: 29

Group type: COMPARATOR
Intervention: Neutral letter (Group 2)
Number of subjects: 29
Study: 30941440

Group type: EXPERIMENTAL
Intervention: Painful shocks administered after presentation of some words (pain condition)
Number of subjects: 0

Group type: COMPARATOR
Intervention: No shocks administered (pain-free condition)
Number of subjects: 0
Study: 28799677

Group type: EXPERIMENTAL
Intervention: Text message (TM) reminders
Number of subjects: 93
Study: 26117402

Group type: EXPERIMENTAL
Intervention: Probiotic group (Lactobacillus curvatus HY7601 and Lactobacillus plantarum KY1032)
Number of subjects: 128
Study: 23619315

Group type: EXPERIMENTAL
Intervention: Dessert served after the main course
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: Dessert served with the main course
Number of subjects: 23

Group type: COMPARATOR
Intervention: Portion size of the main course (reference portion or 50% larger portion)
Number of subjects: 23
Study: 22088414

Group type: COMPARATOR
Intervention: Branded etanercept (25 mg)
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: Biosimilar etanercept (25 mg)
Number of subjects: 23
Study: 19299497

Group type: EXPERIMENTAL
Intervention: Heliox (79% He and 21% O2)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Room air
Number of subjects: 12
Study: 17300242

Group type: EXPERIMENTAL
Intervention: ALA-PDT (20% ALA solution under occlusive dressing for 3 h followed by helium-neon laser irradiation at 100 J cm(‐2) and 100 mW power)
Number of subjects: 86

Group type: EXPERIMENTAL
Intervention: ALA-PDT (after two treatments)
Number of subjects: 86

Group type: COMPARATOR
Intervention: Control (CO2 laser treatment)
Number of subjects: 86

Group type: EXPERIMENTAL
Intervention: ALA-PDT
Number of subjects: 86
Study: 14722514

Group type: EXPERIMENTAL
Intervention: Metformin (850 mg/d)
Number of subjects: 24

Group type: COMPARATOR
Intervention: No treatment
Number of subjects: 24
Study: 11510914

Group type: EXPERIMENTAL
Intervention: Sorbent dialysis
Number of subjects: 20

Group type: COMPARATOR
Intervention: Standardized medical treatment
Number of subjects: 20
Study: 9776434

Group type: EXPERIMENTAL
Intervention: 30 mg of ketorolac
Number of subjects: 57

Group type: COMPARATOR
Intervention: 75 mg of diclofenac
Number of subjects: 57
Study: 7821197

Group type: COMPARATOR
Intervention: Healthy donors (HD)
Number of subjects: 170

Group type: EXPERIMENTAL
Intervention: Insulin-dependent diabetes mellitus (IDDM)
Number of subjects: 170

Group type: EXPERIMENTAL
Intervention: Non-insulin-dependent diabetes mellitus (NIDDM)
Number of subjects: 170

Group type: EXPERIMENTAL
Intervention: Normalization of blood glucose in poorly controlled IDDM patients
Number of subjects: 170

Group type: EXPERIMENTAL
Intervention: Normalization of blood glucose in poorly controlled NIDDM patients
Number of subjects: 170

Group type: EXPERIMENTAL
Intervention: Poorly controlled NIDDM patients
Number of subjects: 170
Study: 2900816

Group type: EXPERIMENTAL
Intervention: 200 mcg of broxaterol hydrochloride
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: 400 mcg of broxaterol hydrochloride
Number of subjects: 12

Group type: COMPARATOR
Intervention: 200 mcg of salbutamol
Number of subjects: 12
Study: 29247365

Group type: EXPERIMENTAL
Intervention: On-lay autologous full-thickness skin graft
Number of subjects: 53

Group type: COMPARATOR
Intervention: Synthetic mesh
Number of subjects: 53
Study: 28431145

Group type: EXPERIMENTAL
Intervention: Lifestyle intervention aimed to reduce body weight
Number of subjects: 407

Group type: EXPERIMENTAL
Intervention: Oral glucosamine sulphate
Number of subjects: 407

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 407
Study: 26408621

Group type: EXPERIMENTAL
Intervention: General anesthesia combined with epidural anesthesia
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Laryngeal mask airway under general anesthesia
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Laryngeal mask airway under general anesthesia combined with epidural block
Number of subjects: 90
Study: 24461666

Group type: EXPERIMENTAL
Intervention: Ivacaftor 150 mg twice daily
Number of subjects: 21

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 21
Study: 20684151

Group type: EXPERIMENTAL
Intervention: Tretinoin gel microsphere (TGM) 0.04% pump
Number of subjects: 170

Group type: COMPARATOR
Intervention: Adapalene 0.1% plus benzoyl peroxide 2.5% gel (ADA-BPO 0.1%/2.5%)
Number of subjects: 170
Study: 18064474

Group type: EXPERIMENTAL
Intervention: Celecoxib 400 mg x 2 daily during radiation
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: Uracil-tegafur 300 mg/m2 daily during radiation
Number of subjects: 35
Study: 17178006

Group type: EXPERIMENTAL
Intervention: Graph design modifications (changing a pie chart to a bar graph)
Number of subjects: 543

Group type: EXPERIMENTAL
Intervention: Graph design modifications (changing the y axis to represent an increase)
Number of subjects: 543

Group type: EXPERIMENTAL
Intervention: Graph design modifications (adding a footnote to explain an acronym)
Number of subjects: 543

Group type: EXPERIMENTAL
Intervention: Graph design modifications (matching the y axis range of two adjacent graphs)
Number of subjects: 543

Group type: COMPARATOR
Intervention: Control group (booklet of 12 graphs from original publications)
Number of subjects: 543
Study: 12591047

Group type: EXPERIMENTAL
Intervention: Acupuncture
Number of subjects: 30

Group type: COMPARATOR
Intervention: Sham
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control (no acupuncture)
Number of subjects: 30
Study: 10966543

Group type: EXPERIMENTAL
Intervention: Diltiazem
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Amiodarone
Number of subjects: 120

Group type: COMPARATOR
Intervention: Digoxin
Number of subjects: 120
Study: 8780092

Group type: EXPERIMENTAL
Intervention: Cabergoline
Number of subjects: 188

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 188
Study: 1611979

Group type: EXPERIMENTAL
Intervention: Ornipressin (POR 8) at a standard concentration of 0.2 i.u./ml
Number of subjects: 231

Group type: COMPARATOR
Intervention: 0.9% NaCl solution (Control)
Number of subjects: 231
Study: 6487471

Group type: EXPERIMENTAL
Intervention: Propranolol
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: Atenolol
Number of subjects: 27

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 27
Study: 30456964

Group type: EXPERIMENTAL
Intervention: Diabetes self-management education (DSME) by certified diabetes educators (CDE) plus usual care
Number of subjects: 140

Group type: COMPARATOR
Intervention: Usual care from family physicians
Number of subjects: 140

Group type: EXPERIMENTAL
Intervention: Diabetes self-management education (DSME)
Number of subjects: 140
Study: 26975694

Group type: EXPERIMENTAL
Intervention: Psychoeducational intervention (six sessions)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Usual treatment (without psychoeducation)
Number of subjects: 0
Study: 24964164

Group type: EXPERIMENTAL
Intervention: Mental Health First Aid (MHFA) training
Number of subjects: 199

Group type: COMPARATOR
Intervention: Waiting list (control group)
Number of subjects: 199
Study: 22846637

Group type: EXPERIMENTAL
Intervention: Acoustic coordinated reset (CR) neuromodulation
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 19713225

Group type: EXPERIMENTAL
Intervention: C-reactive protein in the highest quintile
Number of subjects: 515

Group type: EXPERIMENTAL
Intervention: Family history of myocardial infarction before age 60
Number of subjects: 515

Group type: EXPERIMENTAL
Intervention: Blood pressure in the highest quintile
Number of subjects: 515

Group type: EXPERIMENTAL
Intervention: Obesity
Number of subjects: 515

Group type: COMPARATOR
Intervention: Total cholesterol, low density lipoprotein-cholesterol, high density lipoprotein-cholesterol, triglycerides, glucose, smoking
Number of subjects: 515
Study: 18922613

Group type: COMPARATOR
Intervention: Tooth Mousse (TM) applied for 60 min daily for 7 days; smear layer retained (group 1)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Tooth Mousse (TM) applied for 60 min daily for 7 days; smear layer removed (group 2)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Preconditioning with 30-40% phosphoric acid (PA)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Preconditioning with 20% polyacrylic acid (CC)
Number of subjects: 0
Study: 15795715

Group type: EXPERIMENTAL
Intervention: tissue plasminogen activator (tPA)
Number of subjects: 0

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 0
Study: 12920494

Group type: EXPERIMENTAL
Intervention: Salbutamol via Volumatic
Number of subjects: 44

Group type: COMPARATOR
Intervention: Salbutamol via pMDI
Number of subjects: 44

Group type: COMPARATOR
Intervention: Salbutamol via pMDI plus Volumatic
Number of subjects: 44

Group type: COMPARATOR
Intervention: Salbutamol via Turbuhaler
Number of subjects: 44

Group type: COMPARATOR
Intervention: Salbutamol via Diskus
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: Salbutamol via all devices
Number of subjects: 44
Study: 10392812

Group type: EXPERIMENTAL
Intervention: Medroxyprogesterone acetate (MPA) treatment
Number of subjects: 608

Group type: EXPERIMENTAL
Intervention: Postoperative irradiation (XRT) to the chest wall and/or axillary lymph nodes
Number of subjects: 608

Group type: EXPERIMENTAL
Intervention: Postoperative irradiation (XRT) to the internal mammary nodes
Number of subjects: 608

Group type: EXPERIMENTAL
Intervention: Nodal status and pT
Number of subjects: 608

Group type: EXPERIMENTAL
Intervention: Extracapsular tumour extension (ECE) in node-positive patients
Number of subjects: 608
Study: 8669405

Group type: EXPERIMENTAL
Intervention: Ethanol (5% of total daily energy intake)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Carbohydrate (5% of total daily energy intake)
Number of subjects: 48
Study: 1854979

Group type: EXPERIMENTAL
Intervention: Single-view mammography screening
Number of subjects: 40318

Group type: COMPARATOR
Intervention: No intervention (control group)
Number of subjects: 40318

Group type: EXPERIMENTAL
Intervention: Single-view mammography screening (for women older than 50)
Number of subjects: 40318

Group type: EXPERIMENTAL
Intervention: Single-view mammography screening (for women under 50)
Number of subjects: 40318
Study: 6824898

Group type: EXPERIMENTAL
Intervention: Epidural blockade (T3-4 to L1-2) continuing for 48 hours postoperatively
Number of subjects: 45

Group type: COMPARATOR
Intervention: General anaesthesia
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Epidural blockade with vagus nerve block
Number of subjects: 45
Study: 30180110

Group type: EXPERIMENTAL
Intervention: Online Responsible Marijuana Vendor (RMV) training
Number of subjects: 225
Study: 27993631

Group type: EXPERIMENTAL
Intervention: Target temperature of 33°C
Number of subjects: 939

Group type: COMPARATOR
Intervention: Target temperature of 36°C
Number of subjects: 939

Group type: EXPERIMENTAL
Intervention: Infections (pneumonia, severe sepsis, septic shock)
Number of subjects: 939

Group type: EXPERIMENTAL
Intervention: Procalcitonin (PCT) and C-reactive protein (CRP) levels
Number of subjects: 939
Study: 26430749

Group type: EXPERIMENTAL
Intervention: 1-Hz rTMS to the left temporoparietal cortex region
Number of subjects: 7

Group type: COMPARATOR
Intervention: Sham stimulation to the left temporoparietal cortex region
Number of subjects: 7
Study: 23849700

Group type: EXPERIMENTAL
Intervention: Slow spindles in epileptics
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Fast spindles
Number of subjects: 24

Group type: COMPARATOR
Intervention: Slow spindles in healthy volunteers
Number of subjects: 24
Study: 22039668

Group type: EXPERIMENTAL
Intervention: Recombined interferon alpha‐2b and ribavirin
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Pegylated interferon alpha‐2b and ribavirin
Number of subjects: 50

Group type: COMPARATOR
Intervention: Control group (healthy children)
Number of subjects: 50
Study: 18651884

Group type: EXPERIMENTAL
Intervention: Tao Brush
Number of subjects: 200

Group type: COMPARATOR
Intervention: Pipelle
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Both samplers
Number of subjects: 200
Study: 17187330

Group type: EXPERIMENTAL
Intervention: Inpatient rehabilitation for 3 weeks (n=127)
Number of subjects: 261

Group type: EXPERIMENTAL
Intervention: Inpatient rehabilitation for 4 weeks (n=134)
Number of subjects: 261

Group type: EXPERIMENTAL
Intervention: Inpatient rehabilitation (3 weeks and 4 weeks combined)
Number of subjects: 261

Group type: COMPARATOR
Intervention: Control group (not explicitly mentioned)
Number of subjects: 261
Study: 12830446

Group type: EXPERIMENTAL
Intervention: Nocturnal hemodialysis with monitoring
Number of subjects: 14
Study: 11728147

Group type: EXPERIMENTAL
Intervention: metoprolol + trimetazidine
Number of subjects: 426

Group type: COMPARATOR
Intervention: metoprolol + placebo
Number of subjects: 426
Study: 9151364

Group type: EXPERIMENTAL
Intervention: 20 mg THIP
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 7963155

Group type: EXPERIMENTAL
Intervention: Prednisone (0.5 mg/kg/day)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study: 2953691

Group type: EXPERIMENTAL
Intervention: Heavy-resistance (HR) training
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Explosive strength (EX) training
Number of subjects: 21

Group type: COMPARATOR
Intervention: Both groups together
Number of subjects: 21
Study: 31748705

Group type: EXPERIMENTAL
Intervention: Indapamide
Number of subjects: 126
Study: 29275402

Group type: EXPERIMENTAL
Intervention: Hand-holding (group I)
Number of subjects: 86

Group type: COMPARATOR
Intervention: Non-hand-holding (group II)
Number of subjects: 86
Study: 27863024

Group type: EXPERIMENTAL
Intervention: PCP visits + specialist tele-visits
Number of subjects: 40

Group type: COMPARATOR
Intervention: PCP visits only
Number of subjects: 40